Your browser doesn't support javascript.
loading
When should we consider SGLT-2 inhibitors in patients with acute decompensated heart failure?
Badwan, Osamah Z; Braghieri, Lorenzo; Skoza, Warren; Agrawal, Ankit; Menon, Venu; Tang, W H Wilson.
Affiliation
  • Badwan OZ; Department of Internal Medicine, Cleveland Clinic, Cleveland, OH.
  • Braghieri L; Department of Internal Medicine, Cleveland Clinic, Cleveland, OH.
  • Skoza W; Department of Internal Medicine, Cleveland Clinic, Cleveland, OH.
  • Agrawal A; Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH.
  • Menon V; Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH; Professor, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH.
  • Tang WHW; Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH; Professor, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH tangw@ccf.org.
Cleve Clin J Med ; 91(1): 47-51, 2024 Jan 02.
Article in En | MEDLINE | ID: mdl-38167393
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 / Sodium-Glucose Transporter 2 Inhibitors / Heart Failure Limits: Humans Language: En Journal: Cleve Clin J Med / Clevel. clin. j. med / Cleveland clinic journal of medicine Journal subject: MEDICINA Year: 2024 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 / Sodium-Glucose Transporter 2 Inhibitors / Heart Failure Limits: Humans Language: En Journal: Cleve Clin J Med / Clevel. clin. j. med / Cleveland clinic journal of medicine Journal subject: MEDICINA Year: 2024 Type: Article